NCT06090747

Brief Summary

Breast cancer is the leading cause of mortality in women worldwide. Latin-American women are diagnosed at younger ages, in advanced stages, and with aggressive molecular subtypes. Lifestyle seems related to these aggressive conditions and worse outcomes. The present study seeks to evaluate the effect of a hybrid multidisciplinary intervention for implementing a healthy lifestyle to modify the personal and internal exposome of young women with breast cancer. This randomized controlled experimental study with two groups: Group 1: Hybrid multidisciplinary lifestyle education intervention. Group 2: Individualized hybrid multidisciplinary lifestyle interventions. The multidisciplinary lifestyle intervention program includes oncology, nutrition, physiotherapy, and psychology interventions.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
146

participants targeted

Target at P75+ for not_applicable

Timeline
32mo left

Started Mar 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress54%
Mar 2023Dec 2028

Study Start

First participant enrolled

March 9, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

September 7, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

October 19, 2023

Completed
3.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

October 19, 2023

Status Verified

October 1, 2023

Enrollment Period

3.8 years

First QC Date

September 7, 2023

Last Update Submit

October 13, 2023

Conditions

Keywords

MultidisciplinaryInterventionLifestyleBreast Cancer

Outcome Measures

Primary Outcomes (18)

  • Adoption of healthy lifestyle

    The patient lifestyle compliance measured by the scores of World Cancer Research Fund (WCRF) / American Institute for Cancer Research (AICR) questionnaire, SCORE ≥ 5

    Baseline evaluation and final evaluation (18 months).

  • Changes on 24-hour reminder

    Evaluate the changes on daily nutritional intake (total energy, carbohydrate, protein and, lipids grams)

    Baseline, 3, 6, 12 and 18 months.

  • Education and Motivational effectiveness of digital tools.

    To evaluate the motivational and educational effect of a personalized follow-up by phone, Zoom, WhatsApp, or social networks (number of views in videos, number of Zoom sessions, number o WA calls).

    3, 6, 12 and 18 months.

  • Physical Activity changes

    Evaluate the changes on physical activitiy by International Physical Activity Questionnaire (IPAQ) score (high: 1500 to 3000 METS per/week; moderate: 600 MET per/week.

    Baseline, 3, 6,12 and 18 months.

  • Quality of sleep changes

    Evaluate the quality of sleep changes by Pittsburgh Sleep Quality Index (PSQI). Total Score 0 to 21. Score 0 (No sleep difficulty); Score 1 to7 (mild sleep difficulty); Score 8-14 (moderate sleep dificulty); 15-21 (severe sleep difficulty).

    Baseline, 3, 6,12 and 18 months.

  • Depression risk evaluation

    Patient Health Questionnaire (PHQ-9) 1-4 Minimal depression 5-9 Mild depression 10-14 Moderate depression 15-19 Moderately severe depression 20-27 Severe depression

    Baseline, 3, 6,12 and 18 months.

  • Anxiety risk evaluation

    Generalized Anxiety Disorder Assessment (GAD-7) 0-4: minimal anxiety 5-9: mild anxiety 10-14: moderate anxiety 15-21: severe anxiety

    Baseline, 3, 6,12 and 18 months.

  • Minfulness evaluation - How having a concentrated mind affects on daily life

    Five Facet Mindfulness Questionnaire (FFMQ) 1-2: Lack of concentrated mind 3: Intermediate attention awareness 4-5: Advance attention awareness

    Baseline, 3, 6,12 and 18 months.

  • Body composition - Body fat

    To evaluate the Effect of lifestyle intervention on: Body fat percentage (acceptable fat percentage \<31%)

    Baseline, 3, 6,12 and 18 months.

  • Biochemical parameters - Inflammatory cytokines

    To evaluate the effect of lifestyle intervention on biochemical parameters: Cytokines level

    Baseline, 3, 6,12 and 18 months.

  • Anthropometric measurements - Body weight

    Changes in: Body weight (kg)

    Baseline, 3, 6,12 and 18 months.

  • Minfulness evaluation - Disposition to attention awareness

    Mindful Attention Awareness Scale (MAAS) 1-2: Lack of attention awareness 3: Intermediate attention awareness 4-5: Advance attention awareness 6: Overvalued (questionnaire was notanswered honestly)

    Baseline, 3, 6,12 and 18 months.

  • Minfulness evaluation - Disposition to mindfulness

    Cognitive and Affective Mindfulness Scale-Revised (CAMS-R) 1-2: Lack of disposition 3: Intermediate disposition 4: Advance into mindfulness

    Baseline, 3, 6,12 and 18 months.

  • Body composition - Muscle

    To evaluate the Effect of lifestyle intervention on: Muscle (muscle mass in kg and muscle mass index ≤6.42 kg/m2)

    Baseline, 3, 6,12 and 18 months.

  • Biochemical parameters - Glucose

    To evaluate the effect of lifestyle intervention on biochemical parameters: Blood glucose \<135mg/dL

    Baseline, 3, 6,12 and 18 months.

  • Biochemical parameters - Lipid profile

    To evaluate the effect of lifestyle intervention on biochemical parameters: LDL\<100mg/dL, HDL \>40mg/dL and triglycerides \<150mg/dL)

    Baseline, 3, 6,12 and 18 months.

  • Anthropometric measurements - Waist circumference

    Changes in: Waist circumference (cm)

    Baseline, 3, 6,12 and 18 months.

  • Anthropometric measurements - Waist to hip ratio

    Changes in: Waist to hip ratio (\<0.8)

    Baseline, 3, 6,12 and 18 months.

Secondary Outcomes (4)

  • Improvement of quality of life parameters with lifestyle intervention- QLQ-C30

    Baseline, 3, 6 ,12 and 18 months.

  • Barriers and challenges to implement the lifestyle intervention - CFIR

    3, 6, 12 and 18 months.

  • Barriers and challenges to implement the lifestyle intervention - RE-AIM

    3, 6, 12 and 18 months.

  • Improvement of quality of life parameters with lifestyle intervention- QLQ-BR23

    Baseline, 3, 6 ,12 and 18 months.

Study Arms (2)

Evaluate the effect of hybrid educational intervention in Lifestyle behavior.

ACTIVE COMPARATOR

Group 1: hybrid educational intervention

Behavioral: Hybrid lifestyle educational multidisciplinary intervention.

Evaluate the effect of hybrid personalized intervention in Lifestyle behavior

EXPERIMENTAL

Group 2: hybrid personalized lifestyle intervention delivered by a multidisciplinary team of specialists in oncology, nutrition, psychology, rehabilitation and mindfulness.

Behavioral: Hybrid lifestyle personalized multidisciplinary intervention.

Interventions

Participants will receive a standardized educational healthy lifestyle intervention. The information will be shared via digital tools such as mail, WhatsApp, zoom workshops, educational videos, "Joven, Fuerte y Saludable" webpage, "Joven, Fuerte y Saludable" mobile app, and face-to-face educational sessions.

Evaluate the effect of hybrid educational intervention in Lifestyle behavior.

Participants will receive a standardized educational healthy lifestyle intervention and personalized lifestyle intervention based on their clinical evaluation. Based on clinical records participants will be sent to nutritional, psychological, rehabilitation, and Mindfulness intervention. Educational and motivational strategies include digital tools such as mail, WhatsApp, zoom workshops, educational videos, the "Joven, Fuerte y Saludable" webpage, and the "Joven, Fuerte y Saludable" mobile app. And individualized follow-up through Mobile apps such as AVENA

Evaluate the effect of hybrid personalized intervention in Lifestyle behavior

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women diagnosed with stage I-III BC, confirmed by pathology and image at the INCAN
  • Candidates for multidisciplinary treatment including surgery, chemotherapy, and/or hormonal treatments.
  • Signed the informed consent form
  • Have access to a mobile phone or any electronic device with an active internet connection to receive the program information.

You may not qualify if:

  • Patients with inflammatory cancer
  • Those with cardiomyopathy or ventricular dysfunction (NYHA \>II), arrythmia secondary to left ventricular ejection alterations that requires medication, previous myocardial infarction, or angina pectoris in the last six months
  • Receiving treatment for cardiovascular or cerebrovascular disease, inflammatory bowel disease, malabsorption syndrome, rheumatoid arthritis, lupus, thyroid diseases, or Cushing syndrome
  • Unable to walk for at least 1 km
  • Have cardiovascular, respiratory, or musculoskeletal diseases that impede physical activity
  • Pregnant or breastfeeding
  • Have psychiatric conditions impeding active participation in this protocol
  • Do not understand Spanish

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Marlid Cruz Ramos

México, 14370, Mexico

RECRUITING

Related Publications (40)

  • Amadou A, Torres-Mejia G, Hainaut P, Romieu I. Breast cancer in Latin America: global burden, patterns, and risk factors. Salud Publica Mex. 2014 Sep-Oct;56(5):547-54. doi: 10.21149/spm.v56i5.7379.

    PMID: 25604300BACKGROUND
  • Bessonneau V, Rudel RA. Mapping the Human Exposome to Uncover the Causes of Breast Cancer. Int J Environ Res Public Health. 2019 Dec 27;17(1):189. doi: 10.3390/ijerph17010189.

    PMID: 31892107BACKGROUND
  • Fang M, Hu L, Chen D, Guo Y, Liu J, Lan C, Gong J, Wang B. Exposome in human health: Utopia or wonderland? Innovation (Camb). 2021 Oct 6;2(4):100172. doi: 10.1016/j.xinn.2021.100172. eCollection 2021 Nov 28.

    PMID: 34746906BACKGROUND
  • Daiber A, Kroller-Schon S, Frenis K, Oelze M, Kalinovic S, Vujacic-Mirski K, Kuntic M, Bayo Jimenez MT, Helmstadter J, Steven S, Korac B, Munzel T. Environmental noise induces the release of stress hormones and inflammatory signaling molecules leading to oxidative stress and vascular dysfunction-Signatures of the internal exposome. Biofactors. 2019 Jul;45(4):495-506. doi: 10.1002/biof.1506. Epub 2019 Apr 2.

    PMID: 30937979BACKGROUND
  • Kalita-de Croft P, Sharma S, Sobrevia L, Salomon C. Extracellular vesicle interactions with the external and internal exposome in mediating carcinogenesis. Mol Aspects Med. 2022 Oct;87:101039. doi: 10.1016/j.mam.2021.101039. Epub 2021 Oct 8.

    PMID: 34629184BACKGROUND
  • Barquera S, Hernandez-Barrera L, Trejo-Valdivia B, Shamah T, Campos-Nonato I, Rivera-Dommarco J. [Obesity in Mexico, prevalence andtrends in adults. Ensanut 2018-19.]. Salud Publica Mex. 2020 Nov-Dec;62(6):682-692. doi: 10.21149/11630. Spanish.

    PMID: 33620965BACKGROUND
  • Reynoso-Noveron N, Villarreal-Garza C, Soto-Perez-de-Celis E, Arce-Salinas C, Matus-Santos J, Ramirez-Ugalde MT, Alvarado-Miranda A, Cabrera-Galeana P, Meneses-Garcia A, Lara-Medina F, Bargallo-Rocha E, Mohar A. Clinical and Epidemiological Profile of Breast Cancer in Mexico: Results of the Seguro Popular. J Glob Oncol. 2017 Dec;3(6):757-764. doi: 10.1200/JGO.2016.007377. Epub 2017 Feb 8.

    PMID: 29244990BACKGROUND
  • Villarreal-Garza C, Platas A, Miaja M, Fonseca A, Mesa-Chavez F, Garcia-Garcia M, Chapman JA, Lopez-Martinez EA, Pineda C, Mohar A, Galvez-Hernandez CL, Castro-Sanchez A, Martinez-Cannon BA, Barragan-Carrillo R, Munoz-Lozano JF, Goss P, Bargallo-Rocha JE, Aguilar D, Cardona S, Canavati M. Young Women With Breast Cancer in Mexico: Results of the Pilot Phase of the Joven & Fuerte Prospective Cohort. JCO Glob Oncol. 2020 Mar;6:395-406. doi: 10.1200/JGO.19.00264.

    PMID: 32142405BACKGROUND
  • Shaikh H, Bradhurst P, Ma LX, Tan SYC, Egger SJ, Vardy JL. Body weight management in overweight and obese breast cancer survivors. Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD012110. doi: 10.1002/14651858.CD012110.pub2.

    PMID: 33305350BACKGROUND
  • Bustamante-Marin XM, Merlino JL, Devericks E, Carson MS, Hursting SD, Stewart DA. Mechanistic Targets and Nutritionally Relevant Intervention Strategies to Break Obesity-Breast Cancer Links. Front Endocrinol (Lausanne). 2021 Mar 17;12:632284. doi: 10.3389/fendo.2021.632284. eCollection 2021.

    PMID: 33815289BACKGROUND
  • Villarreal-Garza C, Platas A, Miaja M, Mesa-Chavez F, Garcia-Garcia M, Fonseca A, Pineda C, de la Rosa-Pacheco S, Galvez-Hernandez CL, Bargallo-Rocha E, Castro J, Rodriguez-Gomez D, Cruz-Ramos M, Mohar A. Patients' satisfaction with a supportive care program for young breast cancer patients in Mexico: Joven & Fuerte supports patients' needs and eases their illness process. Support Care Cancer. 2020 Oct;28(10):4943-4951. doi: 10.1007/s00520-020-05334-y. Epub 2020 Feb 4.

    PMID: 32020358BACKGROUND
  • Perry S, Kowalski TL, Chang CH. Quality of life assessment in women with breast cancer: benefits, acceptability and utilization. Health Qual Life Outcomes. 2007 May 2;5:24. doi: 10.1186/1477-7525-5-24.

    PMID: 17474993BACKGROUND
  • Montagnese C, Porciello G, Vitale S, Palumbo E, Crispo A, Grimaldi M, Calabrese I, Pica R, Prete M, Falzone L, Libra M, Cubisino S, Poletto L, Martinuzzo V, Coluccia S, Esindi N, Nocerino F, Minopoli A, Grilli B, Fiorillo PC, Cuomo M, Cavalcanti E, Thomas G, Cianniello D, Pinto M, De Laurentiis M, Pacilio C, Rinaldo M, D'Aiuto M, Serraino D, Massarut S, Caggiari L, Evangelista C, Steffan A, Catalano F, Banna GL, Scandurra G, Ferrau F, Rossello R, Antonelli G, Guerra G, Farina A, Messina F, Riccardi G, Gatti D, Jenkins DJA, Celentano E, Botti G, Augustin LSA. Quality of Life in Women Diagnosed with Breast Cancer after a 12-Month Treatment of Lifestyle Modifications. Nutrients. 2020 Dec 31;13(1):136. doi: 10.3390/nu13010136.

    PMID: 33396551BACKGROUND
  • Ruiz-Vozmediano J, Lohnchen S, Jurado L, Recio R, Rodriguez-Carrillo A, Lopez M, Mustieles V, Exposito M, Arroyo-Morales M, Fernandez MF. Influence of a Multidisciplinary Program of Diet, Exercise, and Mindfulness on the Quality of Life of Stage IIA-IIB Breast Cancer Survivors. Integr Cancer Ther. 2020 Jan-Dec;19:1534735420924757. doi: 10.1177/1534735420924757.

    PMID: 32462950BACKGROUND
  • Ee C, Cave A, Vaddiparthi V, Naidoo D, Boyages J. Factors associated with weight gain after breast cancer: Results from a community-based survey of Australian women. Breast. 2023 Jun;69:491-498. doi: 10.1016/j.breast.2023.01.012. Epub 2023 Jan 25.

    PMID: 36710237BACKGROUND
  • Nyrop KA, Deal AM, Shachar SS, Park J, Choi SK, Lee JT, O'Hare EA, Wheless A, Carey LA, Muss HB. Weight trajectories in women receiving systemic adjuvant therapy for breast cancer. Breast Cancer Res Treat. 2020 Feb;179(3):709-720. doi: 10.1007/s10549-019-05501-8. Epub 2019 Nov 16.

    PMID: 31734823BACKGROUND
  • Richards J, Arensberg MB, Thomas S, Kerr KW, Hegazi R, Bastasch M. Impact of Early Incorporation of Nutrition Interventions as a Component of Cancer Therapy in Adults: A Review. Nutrients. 2020 Nov 5;12(11):3403. doi: 10.3390/nu12113403.

    PMID: 33167544BACKGROUND
  • Li YR, Ro V, Tchou JC. Obesity, Metabolic Syndrome, and Breast Cancer: From Prevention to Intervention. Curr Surg Rep. 2018 Mar;6(3):7. doi: 10.1007/s40137-018-0204-y. Epub 2018 Feb 24.

    PMID: 31293823BACKGROUND
  • Cnop M, Foufelle F, Velloso LA. Endoplasmic reticulum stress, obesity and diabetes. Trends Mol Med. 2012 Jan;18(1):59-68. doi: 10.1016/j.molmed.2011.07.010. Epub 2011 Aug 31.

    PMID: 21889406BACKGROUND
  • Bose S, Allen AE, Locasale JW. The Molecular Link from Diet to Cancer Cell Metabolism. Mol Cell. 2020 Jun 18;78(6):1034-1044. doi: 10.1016/j.molcel.2020.05.018. Epub 2020 Jun 5.

    PMID: 32504556BACKGROUND
  • De Cicco P, Catani MV, Gasperi V, Sibilano M, Quaglietta M, Savini I. Nutrition and Breast Cancer: A Literature Review on Prevention, Treatment and Recurrence. Nutrients. 2019 Jul 3;11(7):1514. doi: 10.3390/nu11071514.

    PMID: 31277273BACKGROUND
  • Hoy MK, Winters BL, Chlebowski RT, Papoutsakis C, Shapiro A, Lubin MP, Thomson CA, Grosvenor MB, Copeland T, Falk E, Day K, Blackburn GL. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. J Am Diet Assoc. 2009 Apr;109(4):688-96. doi: 10.1016/j.jada.2008.12.016.

    PMID: 19328264BACKGROUND
  • Demark-Wahnefried W, Hars V, Conaway MR, Havlin K, Rimer BK, McElveen G, Winer EP. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am J Clin Nutr. 1997 May;65(5):1495-501. doi: 10.1093/ajcn/65.5.1495.

    PMID: 9129482BACKGROUND
  • Makari-Judson G, Braun B, Jerry DJ, Mertens WC. Weight gain following breast cancer diagnosis: Implication and proposed mechanisms. World J Clin Oncol. 2014 Aug 10;5(3):272-82. doi: 10.5306/wjco.v5.i3.272.

    PMID: 25114844BACKGROUND
  • KABAT-ZINN, Jon. Mindfulness-based interventions in context: past, present, and future. 2003.

    BACKGROUND
  • Villarreal-Garza C, Aguila C, Platas A, Lara-Guerra H. [Clinical Forum: Breast cancer in young women in Mexico: unmet needs and clinical challenges]. Rev Invest Clin. 2014 Nov-Dec;66(6):547-58. No abstract available. Spanish.

    PMID: 25729872BACKGROUND
  • Campbell-Enns H, Woodgate R. The psychosocial experiences of women with breast cancer across the lifespan: a systematic review protocol. JBI Database System Rev Implement Rep. 2015 Jan;13(1):112-21. doi: 10.11124/jbisrir-2015-1795.

    PMID: 26447012BACKGROUND
  • Gálvez-Hernández CL, Ortega Mondragón A, Villarreal-Garza C, Ramos Del Río B. Young women with breast cancer: Supportive care needs and resilience. Psicooncologia (Pozuelo de Alarcon). 2018;15(2):287-300.

    BACKGROUND
  • Guarino A, Polini C, Forte G, Favieri F, Boncompagni I, Casagrande M. The Effectiveness of Psychological Treatments in Women with Breast Cancer: A Systematic Review and Meta-Analysis. J Clin Med. 2020 Jan 12;9(1):209. doi: 10.3390/jcm9010209.

    PMID: 31940942BACKGROUND
  • Lengacher CA, Reich RR, Paterson CL, Shelton M, Shivers S, Ramesar S, Pleasant ML, Budhrani-Shani P, Groer M, Post-White J, Johnson-Mallard V, Kane B, Cousin L, Moscoso MS, Romershausen TA, Park JY. A Large Randomized Trial: Effects of Mindfulness-Based Stress Reduction (MBSR) for Breast Cancer (BC) Survivors on Salivary Cortisol and IL-6. Biol Res Nurs. 2019 Jan;21(1):39-49. doi: 10.1177/1099800418789777. Epub 2018 Aug 5.

    PMID: 30079756BACKGROUND
  • Widiasih R, Ermiati, Jayanti TN, Rais Y. Psychosocial Interventions for Improving the Quality of Life in Breast Cancer Survivors: A Literature Review. In: IOP Conference Series: Earth and Environmental Science. Institute of Physics Publishing; 2019.

    BACKGROUND
  • Rogers LQ, Courneya KS, Oster RA, Anton PM, Robbs RS, Forero A, McAuley E. Physical Activity and Sleep Quality in Breast Cancer Survivors: A Randomized Trial. Med Sci Sports Exerc. 2017 Oct;49(10):2009-2015. doi: 10.1249/MSS.0000000000001327.

    PMID: 28538261BACKGROUND
  • Urech C, Grossert A, Alder J, Scherer S, Handschin B, Kasenda B, Borislavova B, Degen S, Erb J, Faessler A, Gattlen L, Schibli S, Werndli C, Gaab J, Berger T, Zumbrunn T, Hess V. Web-Based Stress Management for Newly Diagnosed Patients With Cancer (STREAM): A Randomized, Wait-List Controlled Intervention Study. J Clin Oncol. 2018 Mar 10;36(8):780-788. doi: 10.1200/JCO.2017.74.8491. Epub 2018 Jan 25.

    PMID: 29369731BACKGROUND
  • van den Berg SW, Gielissen MF, Custers JA, van der Graaf WT, Ottevanger PB, Prins JB. BREATH: Web-Based Self-Management for Psychological Adjustment After Primary Breast Cancer--Results of a Multicenter Randomized Controlled Trial. J Clin Oncol. 2015 Sep 1;33(25):2763-71. doi: 10.1200/JCO.2013.54.9386. Epub 2015 Jul 13.

    PMID: 26169621BACKGROUND
  • Dieli-Conwright CM, Wong L, Waliany S, Bernstein L, Salehian B, Mortimer JE. An observational study to examine changes in metabolic syndrome components in patients with breast cancer receiving neoadjuvant or adjuvant chemotherapy. Cancer. 2016 Sep 1;122(17):2646-53. doi: 10.1002/cncr.30104. Epub 2016 May 24.

    PMID: 27219902BACKGROUND
  • Snetselaar LG, de Jesus JM, DeSilva DM, Stoody EE. Dietary Guidelines for Americans, 2020-2025: Understanding the Scientific Process, Guidelines, and Key Recommendations. Nutr Today. 2021 Nov-Dec;56(6):287-295. doi: 10.1097/NT.0000000000000512. Epub 2021 Nov 12.

    PMID: 34987271BACKGROUND
  • Fowler S. Diabetes Prevention Program (V8) . NIDDK Central Repository. 2023; Resources for Research (R4R), https://repository.niddk.nih.gov/.

    BACKGROUND
  • Hauner D, Rack B, Friedl T, Hepp P, Janni W, Hauner H. Rationale and description of a lifestyle intervention programme to achieve moderate weight loss in women with non-metastatic breast cancer: the lifestyle intervention part of the SUCCESS C Study. BMJ Nutr Prev Health. 2020 Sep 21;3(2):213-219. doi: 10.1136/bmjnph-2020-000119. eCollection 2020 Dec.

    PMID: 33521531BACKGROUND
  • Di Meglio A, Martin E, Crane TE, Charles C, Barbier A, Raynard B, Mangin A, Tredan O, Bouleuc C, Cottu PH, Vanlemmens L, Segura-Djezzar C, Lesur A, Pistilli B, Joly F, Ginsbourger T, Coquet B, Pauporte I, Jacob G, Sirven A, Bonastre J, Ligibel JA, Michiels S, Vaz-Luis I. A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design. Trials. 2022 Mar 4;23(1):193. doi: 10.1186/s13063-022-06090-6.

    PMID: 35246219BACKGROUND
  • Febvey-Combes O, Jobard E, Rossary A, Pialoux V, Foucaut AM, Morelle M, Delrieu L, Martin A, Caldefie-Chezet F, Touillaud M, Berthouze SE, Boumaza H, Elena-Herrmann B, Bachmann P, Tredan O, Vasson MP, Fervers B. Effects of an Exercise and Nutritional Intervention on Circulating Biomarkers and Metabolomic Profiling During Adjuvant Treatment for Localized Breast Cancer: Results From the PASAPAS Feasibility Randomized Controlled Trial. Integr Cancer Ther. 2021 Jan-Dec;20:1534735420977666. doi: 10.1177/1534735420977666.

    PMID: 33655799BACKGROUND

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Marlid Cruz Ramos, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: A controlled trial design was adopted in which patients were assigned to two intervention groups according to the nutritional, psychological, or rehabilitation risk at baseline or according to their geographical localization. The first group will receive a hybrid multidisciplinary lifestyle education intervention (control), whereas the second group will receive an individualized hybrid multidisciplinary lifestyle intervention. The study aims to evaluate the effect of both interventions on the internal exposome of young patients with breast cancer and their effect on quality of life. To do this, changes over time in biochemical, inflammatory, and metabolomic indicators will be measured, and validated questionnaires will be applied to assess lifestyle components such as level of physical activity, sleep hygiene, emotional distress, and quality of life (so baseline, during and after treatment).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD

Study Record Dates

First Submitted

September 7, 2023

First Posted

October 19, 2023

Study Start

March 9, 2023

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2028

Last Updated

October 19, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations